Characterization of Smoking‐Induced Nasopharyngeal Lymphoid Hyperplasia

Laryngoscope - Tập 107 Số 12 - Trang 1635-1642 - 1997
Yehuda Finkelstein1, Zvi Malik, J. Kopolovic, J Bernheim, M Djaldetti, Dov Ophir
1Department of Otolaryngology-Head and Neck Surgery, Meir Hospital, Sapir Medical Center, Kfar Saba, Israel

Tóm tắt

AbstractThe frequency of smoking‐induced nasopharyngeal lymphoid hyperplasia in heavy smokers and its potential clinical implications are still unknown. Precise criteria to differentiate this entity from other types of nasopharyngeal lymphoid hyperplasia are needed. A prospective clinicopathological study of smoking‐induced nasopharyngeal lymphoid hyperplasia was conducted in 17 heavy smokers. Ten nonsmoking patients, five of them with chronic sinusitis, three with adult‐onset adenoid hypertrophy, and two children with adenoidal hypertrophy served as a control group. Both in smokers and in nonsmokers, lymphocytic infiltration of the mucosa was characterized immunohisto‐chemically as T cells. In smokers, semithin (1 micron) sections revealed deformed and migrating cytotoxic lymphocytes in the nasopharyngeal mucosa. The lymphocytes were attached to epithelial, ciliated, and goblet cells, resulting in cell damage. Transmission electron microscopy of biopsies from smokers revealed emperipolesis, characterized by mucosal invasion and epithelial cell damage by an unusual population of migrating T lymphocytes that penetrate them. These findings confirm a direct effect of smoking on the nasopharyngeal lymphoid tissue, which forms part of the immune system. It is concluded that the diagnostic evaluation and therapeutic approach of heavy smokers with otological and airway symptoms should be based on thorough endoscopic examination of the nasopharynx. When the diagnosis is not clear‐cut, selective tele‐endoscopic biopsy and electron microscopic examination are recommended. This entity should be added to the list of known clinical manifestations of the smoking habit.

Từ khóa


Tài liệu tham khảo

US Department of Health and Human Services.Strategies to Control Tobacco Use in the United States. NIH Publication No. 92‐3316 October 1991 III‐IV.

Ben‐Sira Z, Smoking: A Follow‐up After Tendency, Weaning and Persistence

10.1001/archotol.1994.01880290029006

10.1017/S0022215100110229

10.1097/00006534-199005000-00004

10.1017/S0022215100114495

10.1001/archotol.1990.01870080050014

10.1097/00006534-195603000-00008

10.1016/S0165-5876(86)80011-8

10.1288/00005537-198402000-00005

Btodsky L, 1988, The role of Haemophilus influenza in the pathogenesis of tonsillar hypertrophy in children, Laryngoscope, 98, 1055, 10.1288/00005537-198810000-00006

Brandtzaeg P, 1987, Immunology of the Ear, 63

Richtsmeier WJ, 1987, The physiology and immunology of the pharyngeal lymphoid tissue, Otolaryngol Clin North Am, 20, 219, 10.1016/S0030-6665(20)31639-X

10.1016/0165-5876(80)90044-0

Horiguti S, 1973, Headache with particular relationship to nasopharyngitis, Bull Tokyo Med Dent Univ, 20, 173

Burns ER, 1982, Cytotoxicity of natural killer cells: correlation with emperipolesis and surface enzyme, Lab Invest, 47, 99

Lyons DJ, 1992, Clark J, et al. Lymphocyte macrophage interactions: peripolesis of human alveolar macrophages, Eur Respir J, 5, 59, 10.1183/09031936.93.05010059

Tobe K, 1982, Electron microscopy of liver lesions in primary biliary cirrhosis. II. A bile duct with chronic non‐suppurative destructive cholangitis, Acta Pathol Jpn, 32, 345

10.1126/science.910131

Hinman LM, 1980, Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking, Am Rev Respir Dis, 121, 263

US Public Health Service. Smoking and Health: A Report of the Surgeon General. Department of Health Education and Welfare Publication no. (PHS) 70‐50066. Washington DC: US Government Printing Office; 1979.

Kew RR, 1986, The role of complement in cigarette smoked‐induced chemotactic activity of lung fluids, Am Rev Respir Dis, 133, 478

10.1172/JCI111760

10.1378/chest.93.4.678

Kauffman F, 1989, The relation between snoring and smoking, body mass index, age, alcohol consumption and respiratory symptoms, Eur Respir J, 2, 599, 10.1183/09031936.93.02070599